Seegene Stock EBITDA
| 096530 Stock | KRW 23,050 250.00 1.10% |
Seegene fundamentals help investors to digest information that contributes to Seegene's financial success or failures. It also enables traders to predict the movement of Seegene Stock. The fundamental analysis module provides a way to measure Seegene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Seegene stock.
Seegene |
Seegene Company EBITDA Analysis
Seegene's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Seegene EBITDA | 415.89 B |
Most of Seegene's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seegene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Seegene reported earnings before interest,tax, depreciation and amortization of 415.89 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The ebitda for all Republic of Korea stocks is notably lower than that of the firm.
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Seegene Fundamentals
| Return On Equity | 0.32 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 3.51 T | |||
| Shares Outstanding | 25.99 M | |||
| Shares Owned By Insiders | 30.90 % | |||
| Shares Owned By Institutions | 9.23 % | |||
| Price To Earning | 140.12 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 1.37 T | |||
| Gross Profit | 1 T | |||
| EBITDA | 415.89 B | |||
| Net Income | 536.56 B | |||
| Cash And Equivalents | 432.13 B | |||
| Total Debt | 102.81 B | |||
| Debt To Equity | 8.90 % | |||
| Current Ratio | 4.91 X | |||
| Cash Flow From Operations | 334.02 B | |||
| Target Price | 52050.0 | |||
| Number Of Employees | 1.01 K | |||
| Beta | -0.97 | |||
| Market Capitalization | 700.48 B | |||
| Total Asset | 1.49 T | |||
| Retained Earnings | 46.11 B | |||
| Working Capital | 139.97 B | |||
| Current Asset | 151.8 B | |||
| Current Liabilities | 11.83 B | |||
| Z Score | 3.6 | |||
| Annual Yield | 0 % | |||
| Net Asset | 1.49 T |
About Seegene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Seegene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seegene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seegene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Seegene Stock
Seegene financial ratios help investors to determine whether Seegene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seegene with respect to the benefits of owning Seegene security.